<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To evaluate the safety and effectiveness of high dose intravenous steroid therapy (HDIST) in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease patients with severe posterior segment <z:hpo ids='HP_0000554'>uveitis</z:hpo> attacks </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Five patients with ocular <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease were treated with HDIST for severe posterior segment attacks </plain></SENT>
<SENT sid="2" pm="."><plain>Two patients had <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, one patient had <z:e sem="disease" ids="C0162293" disease_type="Disease or Syndrome" abbrv="">papillitis</z:e>, and the other two had <z:e sem="disease" ids="C0035333" disease_type="Disease or Syndrome" abbrv="">retinitis</z:e>; four patients also had accompanying severe <z:e sem="disease" ids="C0235812" disease_type="Disease or Syndrome" abbrv="">vitritis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The visual acuities and improvement in ocular signs after HDIST were evaluated </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: During HDIST, patients had no systemic complications caused by treatment </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients responded to HDIST with evidence of a decrease in intraocular inflammatory activity and improved visual acuities within a mean time of 7 (1-15) days of commencing treatment </plain></SENT>
<SENT sid="6" pm="."><plain>During follow up three out of five patients had new posterior segment attacks </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: HDIST is effective in controlling severe, vision threatening <z:hpo ids='HP_0011009'>acute</z:hpo> posterior segment <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's <z:hpo ids='HP_0000554'>uveitis</z:hpo> attacks and in improving visual function in a short period of time </plain></SENT>
</text></document>